Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40A5D | ISIN: US91532F1021 | Ticker-Symbol:
NASDAQ
17.01.25
20:25 Uhr
13,130 US-Dollar
-0,450
-3,31 %
1-Jahres-Chart
UNUSUAL MACHINES INC Chart 1 Jahr
5-Tage-Chart
UNUSUAL MACHINES INC 5-Tage-Chart
ACCESS Newswire
151 Leser
Artikel bewerten:
(0)

Unusual Machines, Inc.: Unusual Machines Adds Electronic Speed Controller to the Blue UAS Framework

Finanznachrichten News

ORLANDO, FLORIDA / ACCESS Newswire / January 17, 2025 / Unusual Machines, Inc. (NYSE American:UMAC), a leading innovator in drone technology with a current focus on U.S. based manufacturing and marketing of drone parts is pleased to announce the release of the Rotor Riot Brave 55A ESC and its addition to the Blue UAS Framework. This product addresses the critical need for non-Chinese, NDAA-compliant components in the U.S. drone industry. Unusual machines now has two drone components placed on the Blue UAS Framework.

The Blue UAS Framework is a program established by the Defense Innovation Unit (DIU) to provide the Department of Defense and other government entities with trusted, secure drone components that meet rigorous cybersecurity, performance, and regulatory standards. Products listed on the framework ensure compliance with federal requirements, such as the National Defense Authorization Act (NDAA), reducing risks associated with foreign-made or unverified components. Inclusion in the Blue UAS Framework underscores Unusual Machines' commitment to supplying reliable solutions for government and defense applications.

The Rotor Riot Brave 55A ESC is a 4-in-1 electronic speed controller designed to work seamlessly with flight controllers such as the Rotor Riot Brave F7. Built with 32-bit processors, the Brave 55A ESC efficiently sends current to Brushless DC Electric motors. The ESC is designed to meet the demands of high-performance drones requiring high motor output for high-speed flight and acrobatics. This product is manufactured in the USA and compliant with NDAA requirements.

"This product expands the market created by the Brave F7 flight controller and furthers our commitment to producing high-quality NDAA-compliant components at competitive prices," said Allan Evans, CEO of Unusual Machines. "The addition of the Brave 55A ESC further establishes us as a trusted partner for the U.S. drone industry."

The Brave 55A ESC will be available for retail sale through the Rotor Riot store, with shipping beginning in March. Enterprise customers can place volume purchase pre-orders by contacting purchasing@rotorriot.com.

Unusual Machines continues to support the American drone industry by prioritizing domestic manufacturing and compliance with evolving regulatory requirements.

About Unusual Machines

Unusual Machines recently initiated U.S.-based manufacturing and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot e-commerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.

For more information, visit Unusual Machines at https://www.unusualmachines.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including our development of a manufacturing business and becoming a leading provider of U.S.drone parts. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The results expected by some or all of these forward-looking statements may not occur. Factors that affect our ability to achieve these results include our ability to manufacture and sell U.S. made drone parts and compete with sale of non-Chinese made drone parts, our ability to expedite the development and deployment of these critical FPV components the impact of the economy on our B2C market including future inflation and a possible recession, the continuation of the wars in Ukraine, and the Middle East, governmental delays, the impact of future U.S. trade policy, any possible U.S. government action taken as a result of the recent surge of drones in New Jersey and elsewhere, and the Risk Factors contained in our with the Securities and Exchange Commission on December 17, 2024. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Any forward-looking statement made by us herein speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether because of new information, future developments or otherwise, except as may be required by law.

Contact:
CS Investor Relations
917-633-8980
investors@unusualmachines.com

SOURCE: Unusual Machines, Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.